how to approach the patient with braf mutant tumor
Published 4 years ago • 4.6K plays • Length 22:40Download video MP4
Download video MP3
Similar videos
-
17:51
how to approach the patient with a braf mutant tumor
-
27:28
advances in therapy for braf-mutant melanoma
-
20:52
what is the optimal therapy for braf mutant metastatic colorectal cancer?
-
30:22
the role of braf and other mutations in progression and malignant transformation, immune tolerance
-
16:56
colorectal cancer with acquired resistance to egfr antibodies: how to manage?
-
10:22
melanoma and braf (pronounced “be-raf”)
-
5:19
targeting braf v600e in metastatic colorectal cancer: where are we today?
-
5:05
anti-her2 mechanisms of approved her2 inhibitors
-
1:26
novel treatment strategies for braf v600e-mutant nsclc
-
1:40
dr. robert on the phase iii combi-v study in braf-mutant melanoma
-
4:51
colorectal cancer debate: first line braf v600e - folfoxiri/bev
-
8:27
debate 2: braf mutant mcrc patients - folfirinox/bev
-
21:10
targeting her2, braf, kras, met
-
26:09
how to improve on the outcome in ras mutant tumors
-
13:59
debate 2: braf mutant mcrc patients - clinical trial
-
5:14
braf mutations across cancers
-
1:32
dr. flaherty on the rationale to explore triplet therapy in braf v600e-mutant melanoma
-
29:45
keynote lecture 4: the braf pathway in crc?
-
3:42
evidence in braf-mutant crc tumors
-
1:35:47
braf-mutated mcrc: from diagnosis to treatment
-
1:17
treatment selection for stage iii braf-mutant melanoma
-
22:44
braf targeted therapy - melanoma education symposium, peter boasberg md